Circ_PSD3 Stimulates Cell Proliferation, Migration, Invasion and Epithelial to Mesenchymal Transition (EMT) in Papillary Thyroid Carcinoma via the Regulation of miR-145-5p/miR-338-3p/HMGB3 Axis
- PMID: 40696971
- DOI: 10.1002/jbt.70402
Circ_PSD3 Stimulates Cell Proliferation, Migration, Invasion and Epithelial to Mesenchymal Transition (EMT) in Papillary Thyroid Carcinoma via the Regulation of miR-145-5p/miR-338-3p/HMGB3 Axis
Abstract
CircRNAs can be applied as tumor biomarkers and potential therapeutic targets. Nevertheless, the function of circ_PSD3 in papillary thyroid carcinoma (PTC) has not been thoroughly explored. The current project attempts to analyze it. RT-qPCR was adopted for measuring the expression of circ_PSD3, HMGB3, miR-145-5p as well as miR-338-3p in PTC tissues and cells. Through performing cell counting kit-8 and transwell experiments, the biological effects of circ_PSD3, HMGB3, miR-145-5p and miR-338-3p on PTC cells were detected. Besides, a dual-luciferase reporter gene was employed to identify the underlying mechanism of circ_PSD3. The Western blot analysis assay was utilized to assess the expression levels of molecular marker proteins associated with epithelial-mesenchymal transition. According to the results, the expressions of circ_PSD3 and HMGB3 showed obvious upregulation in PTC tissues, whereas knockdown of circ_PSD3 or HMGB3 notably hindered cell proliferation, migration as well as invasion in PTC. Mechanistically, it could be discovered that miR-145-5p and miR-338-3p served as the targets of circ_PSD3, and HMGB3 was a target of miR-145-5p and miR-338-3p. Moreover, miR-145-5p and miR-338-3p were discovered to play the role of tumor suppressors in PTC. More importantly, the findings showed that cell proliferation, migration, invasion together with EMT processes were attenuated by circ_PSD3 knockdown, but partially counteracted by miR-338-3p (miR-145-5p) inhibitor or HMGB3 overexpression. Based on the obtained data, circ_PSD3 promotes PTC cell proliferation, migration, invasion and EMT by regulating the miR-145-5p/miR-338-3p/HMGB3 axis. The current work revealed the mechanism of action of circ_PSD3 in PTC and may play the role of a new medical target for PTC.
Keywords: HMGB3; circ_PSD3; miR‐145‐5p; miR‐338‐3p; papillary thyroid carcinoma.
© 2025 Wiley Periodicals LLC.
Similar articles
-
Circular RNA circLIFR suppresses papillary thyroid cancer progression by modulating the miR-429/TIMP2 axis.J Cancer Res Clin Oncol. 2024 Jun 25;150(6):323. doi: 10.1007/s00432-024-05839-7. J Cancer Res Clin Oncol. 2024. PMID: 38914806 Free PMC article.
-
Exosomal circular RNA hsa_circ_007293 promotes proliferation, migration, invasion, and epithelial-mesenchymal transition of papillary thyroid carcinoma cells through regulation of the microRNA-653-5p/paired box 6 axis.Bioengineered. 2021 Dec;12(2):10136-10149. doi: 10.1080/21655979.2021.2000745. Bioengineered. 2021. PMID: 34866540 Free PMC article.
-
The oncogenic role of the circ_0003997/miR-370-3p/HMGA2 axis in papillary thyroid cancer.Endocrine. 2025 Jul 25. doi: 10.1007/s12020-025-04335-3. Online ahead of print. Endocrine. 2025. PMID: 40715934
-
Case Report and Literature Review: Overexpression of HMGA in Concomitant Plurihormonal Tumor and Papillary Thyroid Carcinoma.Neuropathology. 2025 Aug;45(4):e70005. doi: 10.1111/neup.70005. Epub 2025 Mar 20. Neuropathology. 2025. PMID: 40114328 Review.
-
Prognostic Biomarkers for Papillary Thyroid Cancer: Reducing Overtreatment, Improving Clinical Efficiency, and Enhancing Patient Experience.Technol Cancer Res Treat. 2025 Jan-Dec;24:15330338251361633. doi: 10.1177/15330338251361633. Epub 2025 Jul 31. Technol Cancer Res Treat. 2025. PMID: 40740058 Free PMC article. Review.
References
-
- B. R. Roman, L. G. Morris, and L. Davies, “The Thyroid Cancer Epidemic, 2017 Perspective,” Current Opinion in Endocrinology, Diabetes & Obesity 24, no. 5 (2017): 332–336.
-
- A. Coca‐Pelaz, J. P. Shah, J. C. Hernandez‐Prera, et al., “Papillary Thyroid Cancer‐Aggressive Variants and Impact on Management: A Narrative Review,” Advances in Therapy 37, no. 7 (2020): 3112–3128.
-
- M. I. Abdullah, S. M. Junit, K. L. Ng, J. J. Jayapalan, B. Karikalan, and O. H. Hashim, “Papillary Thyroid Cancer: Genetic Alterations and Molecular Biomarker Investigations,” International Journal of Medical Sciences 16, no. 3 (2019): 450–460.
-
- L. S. Kristensen, M. S. Andersen, L. V. W. Stagsted, K. K. Ebbesen, T. B. Hansen, and J. Kjems, “The Biogenesis, Biology and Characterization of Circular RNAs,” Nature Reviews Genetics 20, no. 11 (2019): 675–691.
-
- Y. Yu, G. Dong, Z. Li, Y. Zheng, Z. Shi, and G. Wang, “circ‑LRP6 Contributes to Osteosarcoma Progression by Regulating the miR‑141‑3p/HDAC4/HMGB1 Axis,” International Journal of Oncology 60, no. 4 (2022): 38.
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical